| scholarly article | Q13442814 |
| P50 | author | Anna Veiga Lluch | Q11905662 |
| Megan Munsie | Q38589194 | ||
| Michele De Luca | Q67571078 | ||
| P2093 | author name string | Mahendra Rao | |
| Lars Ahrlund-Richter | |||
| Daniel R Marshak | |||
| P2860 | cites work | Characterization of human embryonic stem cell lines by the International Stem Cell Initiative | Q34638055 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 20-26 | |
| P577 | publication date | 2008-12-08 | |
| P1433 | published in | Cell Stem Cell | Q2943975 |
| P1476 | title | Isolation and production of cells suitable for human therapy: challenges ahead | |
| P478 | volume | 4 |
| Q39508238 | A xeno-free culturing protocol for pluripotent stem cell-derived oligodendrocyte precursor cell production |
| Q38098248 | Adult stem cells for acute lung injury: remaining questions and concerns. |
| Q38179448 | Advances in stem-cell--generated transplantation therapy for Parkinson's disease |
| Q55554954 | Advantages of Graphene Biosensors for Human Stem Cell Therapy Potency Assays. |
| Q37362810 | Age-old wisdom concerning cell-based therapies with added knowledge in the stem cell era: our perspectives |
| Q38376035 | Application of biomaterials to advance induced pluripotent stem cell research and therapy |
| Q42369715 | Autologous and micro-fragmented adipose tissue for the treatment of diffuse degenerative knee osteoarthritis |
| Q92260838 | Autologous micro-fragmented adipose tissue for the treatment of diabetic foot minor amputations: a randomized controlled single-center clinical trial (MiFrAADiF) |
| Q60948085 | Autologous micro-fragmented adipose tissue for the treatment of diffuse degenerative knee osteoarthritis: an update at 3 year follow-up |
| Q38391002 | Cell therapy worldwide: an incipient revolution |
| Q36883541 | Cell therapy: cGMP facilities and manufacturing |
| Q38068560 | Cell therapy: the final frontier for treatment of neurological diseases. |
| Q24615515 | Cell-based therapy for neural disorders--anticipating challenges |
| Q35739401 | Challenges in the translation and commercialization of cell therapies |
| Q56893951 | Chinese newspaper coverage of (unproven) stem cell therapies and their providers |
| Q37666677 | Clinical grade adult stem cell banking |
| Q36925671 | Clinical review: Stem cell therapies for acute lung injury/acute respiratory distress syndrome - hope or hype? |
| Q36008214 | Combination of Sleeping Beauty transposition and chemically induced dimerization selection for robust production of engineered cells |
| Q51101729 | Cryopreservation and Banking of Dental Stem Cells. |
| Q51010111 | Derivation, Expansion, and Motor Neuron Differentiation of Human-Induced Pluripotent Stem Cells with Non-Integrating Episomal Vectors and a Defined Xenogeneic-free Culture System. |
| Q36072885 | Development of a functional schwann cell phenotype from autologous porcine bone marrow mononuclear cells for nerve repair |
| Q30009007 | Differentiation of isolated human umbilical cord mesenchymal stem cells into neural stem cells |
| Q92345232 | Effect of mechanical vibration stress in cell culture on human induced pluripotent stem cells |
| Q37579376 | Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling |
| Q91595574 | Ethical development of stem-cell-based interventions |
| Q41976345 | Expansion of human cord blood hematopoietic stem cells for transplantation |
| Q48191419 | Fresh Noncultured Endothelial Progenitor Cells Improve Neonatal Lung Hyperoxia-Induced Alveolar Injury. |
| Q34461530 | Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects |
| Q59356125 | Generation of Human Induced Pluripotent Stem Cells Using a Defined, Feeder-Free Reprogramming System |
| Q34031759 | Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions |
| Q56786998 | Growth and functional harvesting of human mesenchymal stromal cells cultured on a microcarrier-based system |
| Q45001494 | Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells |
| Q47155904 | High-throughput assessment of mechanical properties of stem cell derived red blood cells, toward cellular downstream processing |
| Q92343230 | Impact of poloxamer 188 (Pluronic F-68) additive on cell mechanical properties, quantification by real-time deformability cytometry |
| Q37179338 | Improved cell therapy protocols for Parkinson's disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons |
| Q90408822 | Intra-Articular Administration of Autologous Micro-Fragmented Adipose Tissue in Dogs with Spontaneous Osteoarthritis: Safety, Feasibility, and Clinical Outcomes |
| Q35652003 | Mesenchymal stem cells - a promising therapy for Acute Respiratory Distress Syndrome |
| Q42475991 | Micromanipulation of culture niche permits long-term expansion of dental pulp stem cells--an economic and commercial angle. |
| Q37279705 | Musings on genome medicine: is there hope for ethical and safe stem cell therapeutics? |
| Q35184232 | Optimizing the production of suspension cells using the G-Rex "M" series |
| Q47305412 | Reactivation of hyperglycemia-induced hypocretin (HCRT) gene silencing by N-acetyl-d-mannosamine in the orexin neurons derived from human iPS cells |
| Q64990548 | Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection. |
| Q35173932 | Regulations and guidelines governing stem cell based products: Clinical considerations |
| Q39026996 | Scalable passaging of adherent human pluripotent stem cells |
| Q38097003 | Stem cell bioengineering strategies to widen the therapeutic applications of haematopoietic stem/progenitor cells from umbilical cord blood. |
| Q59062755 | Stem cell bioprocessing for regenerative medicine |
| Q34557484 | Translating research into clinical scale manufacturing of mesenchymal stromal cells |
| Q33481637 | Xeno-free defined conditions for culture of human embryonic stem cells, neural stem cells and dopaminergic neurons derived from them |
Search more.